COVID-19 In Vitro Diagnostic Medical Device - detail | COVID-19 In Vitro Diagnostic Devices and Test Methods Database

Panbio COVID-19 Ag Test

Manufactured by Abbott Rapid Diagnostics

Manufacturer website

https://www.globalpointofcare.abbott/

CE Marking

Yes

Detection Principle

ImmunoAssay-Antigen

Format

Rapid diagnostic test

Target

Antigen

Commercial Status

Commercialised

Last Update

11/05/20

Test Type

Point-Of-Care test

Test Type Result

qualitative

Specimen

Nasopharyngeal swab

Antigen IgG

Antigen IgM

Antigen IgA

Reader

not required

Time (Min)

Lod

Not found

Sensitivity Percent

91,4 (94,1 for CT <= 33)

Specificity Percent

99.8

Accuracy Percent

Not found

Real-life validation of the Panbio COVID-19 Antigen Rapid Test (Abbott) in community-dwelling subjects with symptoms of potential SARS-CoV-2 infection
Panbio antigen rapid test is reliable to diagnose SARS-CoV-2 infection in the first 7 days after the onset of symptoms

The database contains publicly available In Vitro Diagnostic Medical Devices for COVID-19 and it is being updated periodically. Please note that additional performance (as retrieved from manufacturers web pages) is provided only for devices commercially available with CE-IVD mark. Acknowledgements